Intercept to Present at Upcoming Investor Conferences in June
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Intercept Pharmaceuticals (ICPT) PT Lowered to $106 at Citi
May 30, 2019 7:30 AM EDTCiti analyst Joel Beatty lowered the price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $106.00 (from $140.00) while maintaining a Neutral rating. Beatty believes obeticholic acid is very likely to receive approval for NASH in ~3Q20, and see the drug becoming the standard of care for... More
